Turnstone Biologics Corp.
TSBX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,490 | -$11,806 | -$12,872 | -$17,032 |
| Dep. & Amort. | $0 | $301 | $337 | $491 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $268 | $325 | $704 | $907 |
| Change in WC | $0 | $0 | -$4,293 | -$5,753 |
| Other Non-Cash | $918 | $4,089 | -$352 | $3,902 |
| Operating Cash Flow | -$4,304 | -$7,091 | -$16,476 | -$17,485 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $19 | $1 |
| Net Acquisitions | $0 | $0 | $0 | -$25 |
| Inv. Purchases | $0 | $0 | $0 | -$1 |
| Inv. Sales/Matur. | $0 | $0 | $21,250 | $24,250 |
| Other Inv. Act. | $935 | $12 | $0 | $25 |
| Investing Cash Flow | $935 | $12 | $21,269 | $24,250 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | -$44 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $44 | -$33 |
| Financing Cash Flow | $0 | $0 | $0 | -$33 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3,369 | -$7,079 | $4,793 | $6,732 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $21,963 | $29,042 | $24,249 | $17,517 |
| End Cash | $18,594 | $21,963 | $29,042 | $24,249 |
| Free Cash Flow | -$4,304 | -$7,091 | -$16,457 | -$17,484 |